Editorial introductions : Current Opinion in Cardiology

Secondary Logo

Journal Logo


Editorial introductions

Editor(s): Verma, Subodh; Yanagawa, Bobby; Estep, Jerry

Current Opinion in Cardiology 38(2):p v-vi, March 2023. | DOI: 10.1097/HCO.0000000000001024
  • Free

Current Opinion in Cardiology was launched in 1985. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of cardiology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editor and Section Editors for this issue.


Subodh Verma

Subodh Verma

Dr Subodh Verma is a cardiac surgeon-scientist, Professor and the Canada Research Chair in Cardiovascular Surgery. He is a Fellow of the Canadian Academy of Health Sciences, a member of the Royal Society of Canada College of New Scholars, Artists and Scientists, and a past recipient of the Royal College of Physicians and Surgeons of Canada Gold Medal in Surgery. Dr Verma is the current Scientific Program Committee Chair for the Canadian Society of Cardiac Surgeons. In 2022, Dr Verma was named a Clarivate Highly Cited Researcher in Clinical Medicine. He is an Associate Editor of the European Heart Journal and an active contributor to Canadian clinical practice guidelines. Dr Verma had/has leadership roles in multiple contemporary global heart failure trials – several of which have propelled paradigm changes in heart failure care. He founded the CardioLink platform that united cardiac surgeons from across Canada to conduct robust clinical trials to better inform on surgical decision-making pathways. Dr Verma leads a dynamic pre-clinical and translational research team that leverages pre-clinical disease models and clinical trial-derived data to identify novel mediators of cardiometabolic diseases.

Bobby Yanagawa

Bobby Yanagawa

Bobby Yanagawa is the Division Head, Division of Cardiac Surgery, St Michael's Hospital, Toronto, Canada and Program Director, Division of Cardiac Surgery at the University of Toronto, Canada. Dr Yanagawa obtained his BSc and PhD from the University of British Columbia, Vancouver, Canada and his MD degree and Cardiac Surgery Residency from the University of Toronto, Canada. He has completed research fellowships at the University of Wales College of Medicine, Cardiff, UK, National Cardiovascular Center, Osaka, Japan, and at St Michael's Hospital, Toronto, Canada. He completed an advanced valvular fellowship at Mount Sinai Hospital, New York. Dr Yanagawa's clinical and research interests are, broadly, surgical revascularization, infective endocarditis and equity-diversity-inclusion. He has published over 90 peer reviewed papers, 50 reviews and 15 book chapters including publications in Nature Communications, Nature Medicine, Circulation, Journal of Thoracic and Cardiovascular Surgery and Annals of Thoracic Surgery. He was the AATS 13th Annual C. Walton Lillehei Award winner in 2010.

Jerry Estep

Jerry Estep

Jerry Estep is the current Chairman of Cardiology, Cleveland Clinic, USA. He served as the Section Head of Heart Failure and Heart Transplantation and the Medical Director of the Kaufman Center for Heart Failure and Recovery at Cleveland Clinic in Ohio, USA, from 2018 to 2022. He holds board certification in advanced heart failure (HF) and transplant and cardiovascular disease. Over the past 15 years his primary goal has been to expand clinical, research and education efforts at two large hospital systems. Prior to joining the Cleveland Clinic, Dr Estep served as Medical Director of the Mechanical Circulatory Support Program and Heart Transplant program at Houston Methodist. Both the Cleveland Clinic, Cleveland, USA and Houston Methodist, Houston, USA have comprehensive heart failure programs that leverage multidisciplinary teams to enhance access and referrals with a focus on delivering high quality of care coupled with innovation in research and education.

Dr Estep has authored/coauthored more than 150 manuscripts and/or published abstracts. In addition, he has given over 100 presentations related to heart failure topics at major society meetings and/or at academic institutions. His peer reviewed manuscripts including both original reviews and investigation in several heart failure domains including the role of multimodality imaging to monitor heart failure patients and advanced heart failure topics related to mechanical circulatory support devices and heart transplantation. These manuscripts have been published in the New England Journal of Medicine, Circulation, Journal of the American College of Cardiology (JACC), JACC CV Imaging, and The Journal of Heart and Lung Transplantation (JHLT).

Dr Estep has served as site PI/or co-PI in over 100 clinical trials. He had the privilege of serving as the lead national investigator of the Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP) Study. He was the senior author of multisite randomized controlled trial effort focused on defining the efficacy of a patient-centered Ventricular Assist Device Decision Aid (VADDA Trial). Dr Estep also had the opportunity to serve as Co-Chair for the American Society of Echocardiography (ASE) Guidelines and Statement Document that defined the role of echocardiography to monitor patients supported by left ventricular assist devices (LVADs). He is the current Chair for the ASE updated guidelines statement that defines the role of multimodality imaging to select and monitor patients supported by LVADs and temporary mechanical support devices.

Based on his heart failure and trial expertise, Dr Estep is currently serving as one of the National Co-PIs for the Clinical Study of the BioVentrix Revivent TC System for Treatment of Left Ventricular Aneurysms (ALIVE) NCT02931240.

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.